Articles

  1. Seamless Tech Transfer, Predictable Outcomes Ensuring Success With A Dual-Site Model 4/22/2026

    Technology transfer succeeds through trust, shared knowledge, and disciplined execution. See how collaboration, strong documentation, and digital tools reduce risk on the path to GMP.

  2. U.S. Pharmaceutical Tariffs (Section 232): Implications & Actions 4/16/2026

    New U.S. tariffs are reshaping pharma manufacturing. Early action to assess exposure and pursue onshoring can cut risk, protect margins, and strengthen supply chains.

  3. A Bridge To Global Small Molecule Manufacturing 4/16/2026

    Integrated global small‑molecule development and manufacturing solutions spanning chemistry, analytics, scale‑up, and commercial API supply, designed to reduce CMC risk and accelerate progress.

  4. Understanding And Implementing USP <665> For Single-Use Systems 4/14/2026

    New expectations for single-use systems require structured risk assessment and extractables testing. As compliance deadlines near, practical guidance aligns science, knowledge, regulatory readiness.

  5. Scalable Solutions For High Potent OSD Manufacturing 4/13/2026

    Learn how closed systems, advanced facilities, and flexible batch strategies support safe development and reliable commercial supply.

  6. Safely Scaling High Potency API Manufacturing 4/13/2026

    Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.

  7. Quality Drive + People Powered 4/6/2026

    An integrated development and manufacturing approach that cuts handoffs, manages risk, and accelerates timelines by uniting formulation, analytics, production, and packaging.

  8. Early-Phase Injectable Formulation Development 4/6/2026

    Discover how expert-driven strategies and data-centric tools can help you overcome formulation challenges and accelerate the development of stable, high-performance injectable therapeutics.

  9. Digital Standardization: Accelerating Gene Therapy Tech Transfer With Confidence And Compliance 4/1/2026

    Fragmented, manual data practices slow tech transfer and increase risk; centralized digital CMC systems standardize workflows, improve transparency, and accelerate onboarding while maintaining compliance.

  10. WuXi Biologics Services Overview 3/26/2026

    Learn how integrated R&D and manufacturing streamline the journey from discovery to large-scale production, helping teams advance biologics faster and with greater confidence.